Cerity Partners
RMD icon

Cerity Partners’s ResMed RMD Stock Holding History

Cerity Partners’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.59M Buy
33,822
+6,369
+23% +$1.32M 0.01% 971
2026
Q1 		$6.16M Sell
27,453
-189
-0.7% -$47.1K 0.01% 912
2025
Q4 		$6.66M Sell
27,642
-16,610
-38% -$4.25M 0.01% 818
2025
Q3 		$12.1M Sell
44,252
-819
-2% -$224K 0.02% 509
2025
Q2 		$11.6M Buy
45,071
+29,205
+184% +$6.97M 0.02% 487
2025
Q1 		$3.55M Sell
15,866
-723
-4% -$169K 0.01% 864
2024
Q4 		$3.89M Buy
16,589
+2,903
+21% +$699K 0.01% 821
2024
Q3 		$3.34M Buy
13,686
+6,167
+82% +$1.38M 0.01% 868
2024
Q2 		$1.44M Sell
7,519
-1,128
-13% -$229K ﹤0.01% 1068
2024
Q1 		$1.71M Buy
8,647
+6,643
+331% +$1.22M ﹤0.01% 1049
2023
Q4 		$345K Buy
2,004
+419
+26% +$64.4K ﹤0.01% 1445
2023
Q3 		$234K Buy
1,585
+110
+7% +$19.9K ﹤0.01% 1236
2023
Q2 		$322K Sell
1,475
-5
-0.3% -$1.11K ﹤0.01% 1365
2023
Q1 		$324K Buy
1,480
+243
+20% +$52.7K ﹤0.01% 1500
2022
Q4 		$257K Buy
1,237
+8
+0.7% +$1.76K ﹤0.01% 1213
2022
Q3 		$269K Buy
1,229
+114
+10% +$25.9K ﹤0.01% 942
2022
Q2 		$234K Buy
+1,115
New +$237K ﹤0.01% 1019
2022
Q1 		– Sell
-1,857
Closed -$484K – 1079
2021
Q4 		$484K Buy
1,857
+715
+63% +$186K 0.01% 607
2021
Q3 		$301K Sell
1,142
-3
-0.3% -$820 0.01% 562
2021
Q2 		$282K Sell
1,145
-2
-0.2% -$420 0.01% 601
2021
Q1 		$223K Buy
1,147
+193
+20% +$38.7K 0.01% 631
2020
Q4 		$203K Buy
+954
New +$190K 0.01% 599

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Cerity Partners's RMD Position: Q2 2026 in Review

Cerity Partners increased its ResMed (RMD) stake by 23% in Q2 2026, buying an estimated $1.32M and bringing the position to 33,822 shares worth $6.59M. The position accounts for 0.01% of the portfolio, ranked #971.

Cerity Partners first reported a position in RMD in Q4 2020 and has held it in 22 quarters since. The position peaked at $12.1M in Q3 2025. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Cerity Partners held 33,822 shares of ResMed worth $6.59M as of Q2 2026.
  • Cerity Partners bought 6,369 ResMed shares in Q2 2026, an estimated $1.32M.
  • ResMed made up 0.01% of Cerity Partners's portfolio in Q2 2026, its #971 holding.
  • Cerity Partners first reported a position in ResMed in Q4 2020 and has held it in 22 quarters since.
  • Cerity Partners's ResMed position peaked at $12.1M in Q3 2025.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.